Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;74(8):1417-1426.
doi: 10.2337/db24-0684.

Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia

Affiliations

Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia

Nelly Mauras et al. Diabetes. .

Abstract

Type 1 diabetes has detrimental effects in white matter microstructure. In a longitudinal study, we investigated whether these reported findings change as children grow and enter puberty. At study entry, there were 143 children with type 1 diabetes and 71 control participants without diabetes, 4-9 years old. Brain MRI using diffusion tensor imaging, neurocognitive, and glycemic assessments were performed four times across 6-8 years of follow-up. Longitudinal mixed-effects modeling was used to examine changes in fractional anisotropy (FA), axial diffusivity (AD) (measures of myelination and fiber integrity), radial diffusivity (RD) (axonal leakage), and mean diffusivity (MD) (average diffusion). Associations with glycemic and cognitive measures were assessed. We observed in 182 children (121 type 1 diabetes vs. 61 control participants) who had testing at time 4 that FA increased, and RD, AD, and MD decreased significantly in both groups, with no differences between groups for FA, RD and MD over time. However, children with diabetes had lower AD than control participants at 6-10 years. Differences were not detected at 12 years (age imputed from data), when in puberty. Higher blood glucose levels are associated with lower FA and higher RD and MD. Higher glucose percentage time-in-range was associated with higher FA, reflecting better fiber integrity and myelination and higher cognitive metrics. Within the diabetes group, AD and MD showed no association with neurocognitive outcomes. In summary, white matter AD was decreased in children with diabetes, less so during puberty, and FA was reciprocally related to hyperglycemia. These data suggest continued negative impact of chronic hyperglycemia in the developing brain.

Article highlights: Type 1 diabetes has detrimental effects in white matter in young children. We performed a longitudinal study using brain MRI (diffusion tensor imaging) and cognitive assessments in 4- to 9-year-old children, control participants without diabetes (n = 71) and with type 1 diabetes (n = 143), plus continuous glucose monitoring, to assess changes at four time points as children grow over 6-8 years. White matter myelination and fiber integrity were assessed using axial diffusivity, which was decreased in the diabetes versus control group, less so during puberty, and fractional anisotropy was reciprocally related to hyperglycemia. Data suggest continued negative impact of chronic hyperglycemia in the developing brain.

PubMed Disclaimer

Conflict of interest statement

Duality of Interest. N.M. is co-PI and contact PI of the study and has received grant support through the institution from Dexcom, Medtronic, LifeScan, Beta Bionics, and Novo Nordisk. S.A.W. has received grant support from Abbott and Medtronic, consulting fees from Zealand, and speaker honoraria from Abbott, Dexcom, and Insulet. B.B. has received consultant fees from Medtronic Diabetes, Novo Nordisk, Dexcom, ConvaTec, Lilly, and Tolerion; provided expert testimony for Dexcom; and received research grants from Insulet, Tandem, Medtronic, and Beta Bionics. L.A.F. has received in-kind donations from Dexcom for research. W.V.T. has received consultant fees from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk, and Sanofi and had data safety monitoring board agreements with Eisai, MannKind, and Tolerion. K.E. had a consultant agreement with PicoLife Technology. No other potential conflicts of interest relevant to this article were reported.

References

    1. Marzelli MJ, Mazaika PK, Barnea-Goraly N, et al.; Diabetes Research in Children Network (DirecNet) . Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 2014;63:343–353 - PMC - PubMed
    1. Mazaika PK, Weinzimer SA, Mauras N, et al.; Diabetes Research in Children Network (DirecNet) . Variations in brain volume and growth in young children with type 1 diabetes. Diabetes 2016;65:476–485 - PMC - PubMed
    1. Mauras N, Mazaika P, Buckingham B, et al.; Diabetes Research in Children Network (DirecNet) . Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 2015;64:1770–1779 - PMC - PubMed
    1. Cato MA, Mauras N, Ambrosino J, et al.; Diabetes Research in Children Network (DirecNet) . Cognitive functioning in young children with type 1 diabetes. J Int Neuropsychol Soc 2014;20:238–247 - PMC - PubMed
    1. Cato MA, Mauras N, Mazaika P, et al.; Diabetes Research in Children Network (DirecNet) . Longitudinal evaluation of cognitive functioning in young children with type 1 diabetes over 18 months. J Int Neuropsychol Soc 2016;22:293–302 - PMC - PubMed